AcelRx Pharmaceuticals: Funding, Investors & Team (Sep 2026)
AcelRx Pharmaceuticals is a specialty pharmaceutical company, that engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute postoperative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals was founded in 2005 and is based in Redwood City, California.
AcelRx Pharmaceuticals has raised $17.5M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AcelRx Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jul 2023.
AcelRx Pharmaceuticals Funding Rounds
AcelRx Pharmaceuticals raised $7.5M in an undisclosed round announced in Dec 2022.
7 months later, an undisclosed round of $10.0M was announced in Jul 2023.
AcelRx Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
AcelRx Pharmaceuticals Funding Compared to Other Biotechnology Startups
AcelRx Pharmaceuticals' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AcelRx Pharmaceuticals in Biotechnology and Redwood City
Companies Similar to AcelRx Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
AcelRx Pharmaceuticals Funding FAQs
What does AcelRx Pharmaceuticals do?
AcelRx Pharmaceuticals is a specialty pharmaceutical company, that engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute postoperative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals was founded in 2005 and is based in Redwood City, California.
How much funding has AcelRx Pharmaceuticals raised?
AcelRx Pharmaceuticals has raised $17.5M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Jul 2023.
When did AcelRx Pharmaceuticals last raise funding?
AcelRx Pharmaceuticals' most recent funding round on record is an undisclosed round of $10.0M, announced in Jul 2023.
Who founded AcelRx Pharmaceuticals?
FundedIQ lists Pamela Pierce Palmer (Founder) at AcelRx Pharmaceuticals.
Where is AcelRx Pharmaceuticals headquartered?
AcelRx Pharmaceuticals is based in Redwood City, California, United States.
How many employees does AcelRx Pharmaceuticals have?
AcelRx Pharmaceuticals is in the 51-100 employee band.
How does AcelRx Pharmaceuticals' funding compare to other Biotechnology startups?
AcelRx Pharmaceuticals' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AcelRx Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AcelRx Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.